4,4,5,5-Tetramethyl-2-(3-((4-nitrobenzyl)oxy)phenyl)-1,3,2-dioxaborolane, 10g

1-[(4S)-4-Phenyl-2-thioxo-3-thiazolidinyl]ethanone, 98%, 1g

Éther monobutylique de propylèneglycol, min 99%, pour la synthèse, 5 l, emballage plastique.

TERT-BUTYL 2-(AMINOMETHYL)-1-OXA-8-AZASPIRO[4.5]DECANE-8-CARBOXYLATE, 95.0%, 250mg

1,2-dimethyl-1H-indol-5-ol, 95.0%, 10g

(3R,4R)-1-Benzyl-N,4-dimethylpiperidin-3-amine dihydrochloride, 95.0%, 10g

4-(chlorosulfonyl)-2-fluorobenzoic acid, 97.0%, 1g

2-(Benzo[d]thiazol-2-yl)-4-methylphenol, 98%, 5g

2-Chlorothioanisole>98.0%(GC)5g

2,2-Dimethyl-1-(3-methylphenyl)propan-1-amine, 95%, 250mg

2-Bromo-4-methyl-nicotinic acid ethyl ester, 95.0%, 1g

3-CHLOROQUINOLIN-6-OL, 95.0%, 100mg

6-Methoxy-4-methylpyridine-3-carboxylic acid, 97%, 1g